ENBREL PRO PEDIATRICKÉ POUŽITÍ

10MG INJ PSO LQF 4+4X1ML ISP+4J+4AD

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 13.03.2014
Interruption of marketing 05.03.2014 Lék v jiné síle
Placing on the market 12.01.2012

All reports are available in the Overview.

Back to list